SV40 and human tumours: Myth, association or causality?

Nature Reviews Cancer

Volumn 2, Issue 12, 2002, Pages 957-964

  Gazdar, Adi F ^a   Butel, Janet S ^b   Carbone, Michele ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER GENETICS; CARCINOGENESIS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS 40; VIRAL GENETICS; VIRUS INFECTION; ANIMAL; CELL TRANSFORMATION; DISEASE PREDISPOSITION; GENETICS; MESOTHELIOMA; NEOPLASM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS GENOME;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE SUSCEPTIBILITY; GENOME, VIRAL; HUMANS; MESOTHELIOMA; NEOPLASMS; SIMIAN VIRUS 40;

EID: 0036884063     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc947     Document Type: Review

References (74)

1. zur Hausen, H. Viral Oncogenesis. in Microbes and Malignancy (ed. Personnet, J.) 107-130 (Oxford Press, New York, 1999).
2. Jasani, B. et al. Association of SV40 with human tumours. Semin. Cancer Biol. 11, 49-61 (2001).
3. Imperiale, M. J. The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology 267, 1-7 (2000).
4. Lednicky, J. A. & Butel, J. S. Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors. Semin. Cancer Biol. 11, 39-47 (2001).
5. Stewart, A. R., Lednicky, J. A. & Butel, J. S. Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J. Neurovirol. 4, 182-193 (1998).
6. Gardner, S. D., Field, A. M., Coleman, D. V. & Hulme, B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1, 1253-1257 (1971).
7. Padgett, B. L., Walker, D. L., ZuRhein, G. M., Eckroade, R. J. & Dessel, B. H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1, 1257-1260 (1971).
8. Hahn, W. C. et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation Mol. Cell Biol. 22, 2111-2123 (2002).
9. Krynska, B. et al. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc. Natl. Acad. Sci. USA 96, 11519-11524 (1999).
10. Del Valle, L. et al. Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res. 61, 4287-4293 (2001).
11. Sweet, B. H. & Hilleman, M. R. The vacuolating virus, SV40. Proc. Soc. Exp. Biol. Med. 105, 420-427 (1960).
12. Li, R. M. et al. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J. Am. Soc. Nephrol. 13, 2320-2330 (2002).
13. Bocchetta, M et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc. Natl. Acad. Sci. USA 97, 10214-10219 (2000).
14. Shivapurkar, N. et al. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J. Cell. Biochem. 76, 181-188 (1999).
15. Butel, J. S. & Lednicky, J. A. Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl. Cancer Inst. 91, 119-134 (1999).
16. Carbone, M., Rizzo, P. & Pass, H. I. Simian virus 40, polio vaccines and human tumors: a review of recent developments. Oncogene 15, 1877-1888 (1997).
17. Kops, S. P. Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents. Anticancer Res. 20, 4745-4749 (2000).
18. Shah, K. V. SV40 infections in simians and humans. Dev. Biol. Stand. 94, 9-12 (1998).
19. Melnick, J. L. & Stinebaugh, S. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral polio vaccine. Proc. Soc. Exp. Biol. Med. 109, 965-968 (1962).
20. Ashekenazi, A. & Melnick, J. L. Induced latent infection of monkeys with vacuolating SV-40 papova virus: virus in kidneys and unne. Proc. Soc. Exp. Biol. Med. 111, 367-372 (1962).
21. Leithner, A. et al. Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas. Cancer Biol. Ther. 1, 373-379 (2002).
22. Hirvonen, A. et al. Simian virus 40 (SV40)-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol. Carcinog. 26, 93-99 (1999).
23. De Rienzo, A. et al. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J. Cell Biochem. 84, 455-459 (2002).
24. Carbone, M., Stach, R., Di Resta, I., Pass, H. I. & Rizzo, P. Simian virus 40 oncogenesis in hamsters, Dev. Biol. Stand 94, 273-279 (1998).
25. Shivapurkar, N. et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 359, 851-852 (2002).
26. Bergsagel, D. J., Finegold, M. J., Butel, J. S., Kupsky, W. J. & Garcea, R. L. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N. Engl. J. Med 326, 988-993 (1992).
27. Huang, H. et al. Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol. 9, 33-42 (1999).
28. Lednicky, J. A., Garcea, R. L., Bergsagel, D. J. & Butel, J. S. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212, 710-717 (1995).
29. Krieg, P. & Scherer, G. Cloning of SV40 genomes from human brain tumors. Virology 138, 336-340 (1984).
30. Carbone, M. et al. SV40-like sequences in human bone tumors. Oncogene 13, 527-535 (1996).
31. Vilchez, R. A. et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 359, 817-823 (2002).
32. Rizzo, P. et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 116, 470S-473S (1999).
33. Rizzo, P., Di Resta, I., Powers, A., Ratner, H. & Carbone, M. Unique strains of SV40 in commercial polio vaccines from 1955 not readily identifiable with current testing for SV40 infection Cancer Res. 59, 6103-6108 (1999).
34. Cicala, C., Pompetti, F. & Carbone, M. SV40 induces mesotheliomas in hamsters Am. J. Pathol. 142, 1524-1533 (1993).
35. Carbone, M. et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9, 1781-1790 (1994).
36. Rizzo, P. et al. SV40 and the pathogenesis of mesothelioma. Semin. Cancer Biol. 11, 63-71 (2001).
37. Shivapurkar, N. et al. Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomas. Int. J. Cancer 85. 743-745 (2000).
38. Testa, J. R. et al. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res. 58, 4505-4509 (1998).
39. Toyooka, S. et al. Aberrant methylation and simian virus 40 Tag sequences in malignant mesothelioma. Cancer Res. 61, 5727-5730 (2001).
40. Carbone, M., Kratzke, R. A. & Testa, J. R. The pathogenesis of mesothelioma. Semin. Oncol. 29, 2-17 (2002).
41. Schrump, D. S. & Waheed, I. Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesotheliomas. Semin. Cancer Biol. 11, 73-80 (2001).
42. Foddis, R. et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 21, 1434-1442 (2002).
43. Toyooka, S. et al. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Oncogene 21, 4340-4344 (2002).
44. Wong, J. M., Kusdra, L. & Collins, K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nature Cell Biol. 4, 731-736 (2002).
45. Ewald, D. et al. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273, 1384-1386 (1996).
46. Salewski, H et al. Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53. Cancer Res 59, 1980-1986 (1999).
47. Tzeng, Y. J. et al. SV4O T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors. Oncogene 16, 2103-2114 (1998).
48. Niedobitek, G., Meru, N. & Delecluse, H. J. Epstein-Barr virus infection and human malignancies. Int. J. Exp. Pathol. 82, 149-170 (2001).
49. Strickler, H. D. A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epidemiol. Biomarkers Prev. 10, 523-532 (2001).
50. Innis, M. D. Oncogenesis and poliomyelitis vaccine. Nature 219, 972-973 (1968).
51. Heinonen, O. P. et al. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int. J. Epidemiol. 2, 229-235 (1973).
52. Farwell, J. R., Dohrmann, G. J. & Flannery, J. T. Medulloblastoma in childhood: an epidemiological study. J. Neurosurg. 61, 657-664 (1984).
53. Carbone, M., Fisher, S., Powers, A., Pass, H. I. & Rizzo, P. New molecular and epidemiological issues in mesothelioma: role of SV40. J. Cell. Physiol. 180, 167-172 (1999).
54. Strickler, H. D. et al. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 279, 292-295 (1998).
55. Butel, J. S. et al. Evidence of SV40 infections in hospitalized children. Hum. Pathol. 30, 1496-1502 (1999).
56. Vastag, B. Sewage yields clues to SV40 transmission. JAMA 288, 1337-1338 (2002).
57. Butel, J. S. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21, 405-426 (2000).
58. Klein, G., Powers, A. & Croce, C. Association of SV40 with human tumors. Oncogene 21, 1141-1149 (2002).
59. Malkin, D. Simian virus 40 and non-Hodgkin lymphoma. Lancet 359, 812-813 (2002).
60. Bradford-Hill, A. The environment and disease: association or causation? Proc. R. Soc. Med. 9, 295-300 (1965).
61. zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev. Cancer 2, 342-350 (2002).
62. Cacciotti, P. et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation a model for viral-related carcinogenesis of human malignant mesothelloma. Proc. Natl. Acad. Sci. USA 98, 12032-12037 (2001).
63. Cecciotti, P. et al. The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor. Am. J. Respir. Cell. Mol. Biol. 26, 189-193 (2002).
64. Manning, C. B. et al. A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression. Cancer Res. 62, 4169-4175 (2002).
65. Bocchetta, M., Miele, L., Pass, H. I. & Carbone, M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. (in the press) (2002).
66. Eddy, B. E., Borman, G. S., Grubbs, G. E. & Young, R. D. Identification of the oncogenic substance in rhesus monkey cell cultures as simian virus 40. Virology 17, 65-75 (1962).
67. Shein, H. M. & Enders, J. F. Multiplication and cytopathogenicity of simian vacuolating virus 40 in cultures of human tissues. Proc. Soc. Exp. Biol. Med. 109, 495-500 (1962).
68. Jensen, F., Koprowski H., Pagano, J. S., Pontén, J. & Ravdin, R. G. Autologous and homologous implantation of human cells transformed in vitro by simian virus 40. J. Natl. Cancer Inst. 32, 917-937 (1964).
69. Bastian, F. O. Papova-like virus particles in a human brain tumor. Lab. Invest. 25, 169-175 (1971).
70. Brugge, J. S. & Butel, J. S. Role of simian virus 40 gene A function in maintenance of transformation. J Virol. 15, 619-635 (1975).
71. Ilyinskii, P. O., Daniel, M. D., Horvath, C. J. & Desrosiers, R. C. Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J. Virol. 66, 6353-6360 (1992).
72. Carbone, M. et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nature Med. 3, 908-912 (1997).
73. Ramael, M. et al. Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma. Eur. Respir. J. 14, 1381-1386 (1999).
74. Waheed, I. et al. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells, Cancer Res. 59, 6068-6073 (1999).